Abstract
The interferon-γ (IFN-γ) productivity of peripheral blood mononuclear cells (PBMCs) was examined in 30 patients with uterine cervical cancer. The patients under 50 years of age had decreased IFN-γ production compared with the age-matched controls. The IFN-γ productivity in the patients over 50 years of age was decreased as well as in the age-matched controls. The proportion of monocytes in PBMCs did not correlate with the IFN-γ productivity. The prostaglandin E2 (PGE2) productivity of PBMCs increased with the progress of cancer. PGE2 inhibited the IFN-γ production by PBMCs, and the sensitivity of PBMCs to PGE2 was increased in the patients and controls over 60 years of age. The addition of indomethacin resulted in an increase in IFN-γ production by PBMCs. These results suggest that the increased production of PGE2 and/or increased sensitivity to PGE2 are responsible for the decreased IFN-γ production in patients with cervical cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Maeyer ED, Maeyer-Guignard JD: Production of IFN-γ by T cells and modulation of T cell, B cell, and NK cell activity by interferons.In Interferons and Other Regulatory Cytokines, ED Maeyer, JD Maeyer-Guignard (eds). New York, John Wiley & Sons, 1988, pp 221–273
Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlick JR, Vilcek J: Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 131:2821–2826, 1983
Schultz RM, Kleinschmidt NJ: Functional identity between murine γ interferon and macrophage activating factor. Nature 305:239–240, 1983
Chen L, Tourvieille B, Burns GF, Mathieu-Mahul D, Sasportes M, Bensussan A: Interferon: A cytotoxic T lymphocyte differentiation signal. Eur J Immunol 16:767–770, 1986
Platsoucas CD: Regulation of natural killer cytotoxicity byE. coli-derived human interferon γ. Scand J Immunol 24:93–108, 1986
Levy S, Kopersztych S, Musatti CC, Souen JS, Salvatore CA, Mendes NF: Cellular immunity in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol 130:160–164, 1978
Shiraki S, Mori H, Kadomoto N, Nakano T, Yamada Y, Noda K: Adjuvant immunotherapy of carcinoma colli with levamisole: Prevention of immunological depression following surgical therapy and radiotherapy. Int J Immunopharm 4:73–80, 1982
Epstein LB, Cline MJ, Merigan TC: The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon. J Clin Invest 50:744–753, 1971
Goodwin JS, Messner RP, Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. J Clin Invest 62:753–760, 1978
Rappaport RS, Dodge GR: Prostaglandin E inhibits the production of human interleukin-2. J Exp Med 155:943–948, 1982
Kurland JI, Bockman R: Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 147:952–960, 1978
Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55, 1984
Archer DL, Smith BG, Ulrich JT, Johnson HM: Immune interferon induction by T-cell mitogens involves different T-cell subpopulations. Cell Immunol 48:420–426, 1979
Epstein LB, Gupta S: Human T-lymphocyte subset production of immune (γ) interferon. J Clin Immunol 1:186–194, 1981
Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K: Natural killer (NK) cells as a responder to interleukin 2 (IL2). II. IL2-induced interferon γ production. J Immunol 130:988–992, 1983
Torres BA, Farrar WL, Johnson HM: Interleukin 2 regulated immune interferon (IFNγ) production by normal and suppressor cell cultures. J Immunol 128:2217–2219, 1982
Torres BA, Yamamoto JK, Johnson HM: Cellular regulation of immune interferon (IFNγ) product: Lyt phenotype of suppressor cell. Infect Immun 35:770–776, 1982
Torres BA, Russell JK, Johnson HM: Eicosanoids and gamma interferon.In Prostaglandins in Cancer Research, E Garaci, R Paoletti, MG Santoro (eds). Berlin, Springer-Verlag, 1987, pp 227–234
Picker LJ, Raff HV, Goldyne ME, Stobo JD: Metabolic heterogeneity among human monocytes and its modulation by PGE2. J Immunol 124:2557–2562, 1980
Khansari N, Chou YK, Fudenberg HH: Human monocyte heterogeneity: Interleukin 1 and prostaglandin E2 product by separate subsets. Eur J Immunol 15:48–51, 1985
Walford RL: The immunologic theory of aging: current status. Fed Proc 33:2020–2027, 1974
Yabrov AA: Interferon and Nonspecific Resistance. New York, Human Sciences Press, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mori, H., Hanabayashi, T., Yamada, Y. et al. Decrease in interferon-γ production by peripheral blood mononuclear cells in patients with uterine cervical cancer. J Clin Immunol 10, 45–51 (1990). https://doi.org/10.1007/BF00917497
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00917497